1. National Cooperative Crohn's Disease Study: results of drug treatment;Summers, R.W.; Switz, D.M.; JT, Jr, Sessions; Becktel, J.M.; Best, W.R.; J, Jr, Kern;Gastroenterology,1979
2. European Cooperative Crohn's Disease Study: results of drug treatment;Malchow, H.; Ewe, K.; Brandes, J.W.; Goebell, H.; Ehms, H.; Somer, H.;Gastroenterology,1984
3. New developments in the use of 5-aminosalicylic acid in patients with inflammatory bowel disease;Thompson, A.B.R.;Aliment Pharnacol Therap,1991
4. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial;Singleton, J.W.; Hanauer, S.B.; Gitnick, G.L.; Peppercorn, M.A.; Robinson, M.G.; Wruble, L.D.
5. Efficacy of 5-ASA enemas versus hydrocortisone enemas in ulcerative colitis;Campieri, M.; Gionchetti, P.; Beluzzi, A.; Brignola, C.; Migaldi, M.; Tabanelli, G.M.;Dig Dis Sci; Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial,1987